Plasma procalcitonin in rheumatic diseases;Il dosaggio della procalcitonina plasmatica in reumatologia

Reumatismo

Volumn 55, Issue 2, 2003, Pages 113-118

  Scire C A ^a   Caporali, R ^a   Perotti, C ^a   Montecucco, Carlomaurizio ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b Cattedra e U Opera di Reumatologia   (Italy)

Author keywords

Autoimmune diseases; Procalcitonin; SLE; Systemic infection

Indexed keywords

ADRENOMEDULLIN; AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE DISEASE; BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; GENE; HUMAN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHEUMATIC DISEASE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; CALCITONIN; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOSES; PROTEIN PRECURSORS; RHEUMATIC DISEASES; VIRUS DISEASES; WEGENER GRANULOMATOSIS;

EID: 0038682123     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Moya F, Nieto A, R-Candela JL. Calcitonin biosynthesis: evidence for a precursor. Eur J Biochem 1975; 55: 407-13.
2. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
3. Reinhart K, Karzai W. Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26: 1193-200.
4. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002; 323: 17-29.
5. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-6.
6. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134: 49-55.
7. Monneret G, Laroche B, Bienvenu J. Procalcitonin is not produced by circulating blood cells. Infection 1999; 27: 34-5.
8. Sauer M, Tiede K, Volland R, Fuchs D, Zintl F. Procalcitonin in comparison to C-reactive protein as markers of the course of sepsis in severely immunocompromised children after bone marrow transplantation. Klin Padiatr 2000; 212: 10-5. [Abstract]
9. Bracq S, Machairas M, Clement B, Pidoux E, Andreoletti M, Moukhtar MS, et al. Calcitonin gene expression in normal human liver. FEBS Lett 1993; 331: 15-8.
10. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28: 458-61.
11. Silomon M, Bach F, Ecker D, Graeter T, Grundmann U, Larsen R. Procalcitonin after extracorporeal circulation. Synthesis in the hepatosplanchnic region. Anaesthesist 1999; 48: 395-8. [Abstract]
12. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86: 396-404.
13. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-8.
14. Monneret G. Dear PCT, you are not a specific marker of bacterial infection. Intensive Care Med 2002; 28: 377-8.
15. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28: 458-61.
16. Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, Reinhart K. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 1999; 27: 1814-8.
17. Sabat R, Hoflich C, Docke WD, Oppert M, Kern F, Windrich B, et al. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med 2001; 27: 987-91.
18. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26: 1001-6.
19. Monneret G, Pachot A, Laroche B, Picollet J, Bienvenu J. Procalcitonin and calcitonin gene-related peptide decrease LPS-induced TNF production by human circulating blood cells. Cytokine 2000; 12: 762-4.
20. Hoffmann G, Totzke G, Seibel M, Smolny M, Wiedermann FJ, Schobersberger W. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med 2001; 29: 112-6.
21. Hoffmann G, Czechowski M, Schloesser M, Schobersberger W. Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002; 30: 2091-5.
22. Lind L, Carlstedt F, Rastad J, Stiernstrom H, Stridsberg M, Ljunggren O, et al. Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med 2000; 28: 93-9.
23. Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huyghens L, et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30: 757-62.
24. Espinosa-Morales R, Escalante A. Use of procalcitonin as a diagnostic test: comment on the article by Eberhard et al. Arthritis Rheum 1998; 41: 567-8.
25. Moosig F, Reinhold-Keller E, Csernok E, Gross WL. Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al. Arthritis Rheum 1998; 41: 566-7.
26. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol 1998; 25: 1531-3.
27. Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998; 26: 274-6.
28. Shin KC, Lee YJ, Kang SW, Baek HJ, Lee EB, Kim HA, et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis 2001; 60: 988-9.
29. Sitter T, Schmidt M, Schneider S, Schiffl H. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 2002; 15: 297-301.
30. Soderquist B, Jones I, Fredlund H, Vikerfors T. Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scand J Infect Dis 1998; 30: 591-6.